Cargando…

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer

Detalles Bibliográficos
Autor principal: Miller, WR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300238/
http://dx.doi.org/10.1186/bcr1546
_version_ 1782226233492242432
author Miller, WR
author_facet Miller, WR
author_sort Miller, WR
collection PubMed
description
format Online
Article
Text
id pubmed-3300238
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33002382012-03-14 Evolution of aromatase inhibitors as an endocrine treatment for breast cancer Miller, WR Breast Cancer Res Oral Presentation BioMed Central 2006 2006-11-01 /pmc/articles/PMC3300238/ http://dx.doi.org/10.1186/bcr1546 Text en Copyright ©2006 BioMed Central Ltd
spellingShingle Oral Presentation
Miller, WR
Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
title Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
title_full Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
title_fullStr Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
title_full_unstemmed Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
title_short Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
title_sort evolution of aromatase inhibitors as an endocrine treatment for breast cancer
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300238/
http://dx.doi.org/10.1186/bcr1546
work_keys_str_mv AT millerwr evolutionofaromataseinhibitorsasanendocrinetreatmentforbreastcancer